 |
Top 10 Stem cells startups in USA
Updated: May 01, 2024 |
1
Funding: $1.3B
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
2
Funding: $1.2B
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
3
Funding: $560M
Century Therapeutics is harnessing the power of adult stem cells to develop curative therapies for cancer. It develops iPSC-derived, allogeneic immune cell therapy products for cancer
Century Therapeutics is harnessing the power of adult stem cells to develop curative therapies for cancer. It develops iPSC-derived, allogeneic immune cell therapy products for cancer
4
Funding: $445M
Rubius is developing a new class of drugs, Red-Cell Therapeutics. Rubius is using advanced cellular therapies that harness the unique, inherent properties of red cells and marry them to the creative power of genetic engineering.
Rubius is developing a new class of drugs, Red-Cell Therapeutics. Rubius is using advanced cellular therapies that harness the unique, inherent properties of red cells and marry them to the creative power of genetic engineering.
5
Funding: $405.9M
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients.
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients.
6
Funding: $400M
Celgene spinout that aims is to develop cells from placentas against blood cancers and is founded on the use of stem cells from placentas. The goal is to create therapies across autoimmune and degenerative disease, immuno-oncology, and functional regeneration.
Celgene spinout that aims is to develop cells from placentas against blood cancers and is founded on the use of stem cells from placentas. The goal is to create therapies across autoimmune and degenerative disease, immuno-oncology, and functional regeneration.
7
Funding: $264M
Aspen Neuroscience is a private biotechnology company that uses innovative genomic approaches combined with stem cell biology.
Aspen Neuroscience is a private biotechnology company that uses innovative genomic approaches combined with stem cell biology.
8
Funding: $235.5M
ViaCyte is a leader in the emerging field of regenerative medicine. ViaCyte's innovative product is based on the differentiation of stem cells into pancreatic beta cell precursors, with subcutaneous implantation in a retrievable and immune-protective encapsulation medical device. Once implanted, the precursor cells mature into endocrine cells that secrete insulin and other hormones in a regulated manner to control blood glucose levels. ViaCyte's goal is a product that can free patients with type 1 and type 2 diabetes from long-term insulin dependence.
ViaCyte is a leader in the emerging field of regenerative medicine. ViaCyte's innovative product is based on the differentiation of stem cells into pancreatic beta cell precursors, with subcutaneous implantation in a retrievable and immune-protective encapsulation medical device. Once implanted, the precursor cells mature into endocrine cells that secrete insulin and other hormones in a regulated manner to control blood glucose levels. ViaCyte's goal is a product that can free patients with type 1 and type 2 diabetes from long-term insulin dependence.
9
Funding: $163M
Semma Therapeutics was founded to develop transformative therapies for patients who currently depend on insulin injections.
Semma Therapeutics was founded to develop transformative therapies for patients who currently depend on insulin injections.
10
Funding: $138M
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
Ad
Advertise your startup
11
Funding: $135.5M
QurAlis is specifically focused on discovering & developing new therapies for amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease.
QurAlis is specifically focused on discovering & developing new therapies for amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease.
12
Funding: $129.6M
Cellular Dynamics International (CDI), a FUJIFILM company, is a leading developer and manufacturer of human cells used in drug discovery, toxicity testing, stem cell banking, and cell therapy development. The Company partners with innovators from around the world to combine biologically relevant human cells with the newest technologies to drive advancements in medicine and healthier living.
Cellular Dynamics International (CDI), a FUJIFILM company, is a leading developer and manufacturer of human cells used in drug discovery, toxicity testing, stem cell banking, and cell therapy development. The Company partners with innovators from around the world to combine biologically relevant human cells with the newest technologies to drive advancements in medicine and healthier living.
13
Funding: $97.5M
Cellino is on a mission to make personalized, autologous stem cell therapies accessible for patients. Cellino’s platform combines label-free imaging and high-speed laser editing with machine learning to automate cell reprogramming
Cellino is on a mission to make personalized, autologous stem cell therapies accessible for patients. Cellino’s platform combines label-free imaging and high-speed laser editing with machine learning to automate cell reprogramming
14
Funding: $95M
Osiris Therapeutics is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources. One of its products, Stromagen was used to treat breast cancer in clinical trials.
Osiris Therapeutics is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources. One of its products, Stromagen was used to treat breast cancer in clinical trials.
15
Regenexx focuses on developing breakthrough non-surgical options for people suffering from various orthopedic disorders. We have developed a patent-pending procedure that uses your own stem cells and blood growth factors to regenerate bone and cartilage.
16
Funding: $37.6M
StemoniX is revolutionizing the production, growth, and development of stem cell and stem cell technologies.
StemoniX is revolutionizing the production, growth, and development of stem cell and stem cell technologies.
17
Creative Medical Technology Holdings is a clinical-stage biotechnology company focused on treating erectile dysfunction and stroke using stem cell treatments.
18
Funding: $20.4M
Curi Bio is integrating human iPSC-derived cells, tissue-specific biosystems, and AI-enabled data analytics of new therapeutics.
Curi Bio is integrating human iPSC-derived cells, tissue-specific biosystems, and AI-enabled data analytics of new therapeutics.
19
Funding: $15.9M
We design transformational gene therapies that aim to enhance the body's own defenses to defeat disease.
We design transformational gene therapies that aim to enhance the body's own defenses to defeat disease.
20
Oscine Therapeutics is harnessing the power of stem cell science to revolutionize treatment of CNS diseases